| Refractory anemia with excess of blasts | |
|---|---|
| Specialty |
Oncology
 |
Refractory anemia with excess of blasts (RAEB) is a type of myelodysplastic syndrome [1] with a marrow blast percentage of 5% to 19%. [2]
In MeSH, "Smoldering leukemia" is classified under RAEB. [3]
References
- ^ Palmieri S, D'Arco AM, Celentano M, et al. (July 2006). "An antecedent diagnosis of refractory anemia with excess blasts has no prognostic relevance in acute myeloid leukemia of older adult patients". Ann. Oncol. 17 (7): 1146–51. doi: 10.1093/annonc/mdl083. PMID 16687417.
- ^ Estey E, Thall P, Beran M, Kantarjian H, Pierce S, Keating M (October 1997). "Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy". Blood. 90 (8): 2969–77. doi: 10.1182/blood.V90.8.2969. PMID 9376577.
- ^ Leukemia,+Smoldering at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
External links
- Smoldering leukemia entry in the public domain NCI Dictionary of Cancer Terms
This article incorporates
public domain material from
Dictionary of Cancer Terms.
U.S. National Cancer Institute.
 | This oncology article is a stub. You can help Wikipedia by expanding it. |
| Refractory anemia with excess of blasts | |
|---|---|
| Specialty |
Oncology
|
Refractory anemia with excess of blasts (RAEB) is a type of myelodysplastic syndrome [1] with a marrow blast percentage of 5% to 19%. [2]
In MeSH, "Smoldering leukemia" is classified under RAEB. [3]
References
- ^ Palmieri S, D'Arco AM, Celentano M, et al. (July 2006). "An antecedent diagnosis of refractory anemia with excess blasts has no prognostic relevance in acute myeloid leukemia of older adult patients". Ann. Oncol. 17 (7): 1146–51. doi: 10.1093/annonc/mdl083. PMID 16687417.
- ^ Estey E, Thall P, Beran M, Kantarjian H, Pierce S, Keating M (October 1997). "Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy". Blood. 90 (8): 2969–77. doi: 10.1182/blood.V90.8.2969. PMID 9376577.
- ^ Leukemia,+Smoldering at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
External links
- Smoldering leukemia entry in the public domain NCI Dictionary of Cancer Terms
This article incorporates
public domain material from
Dictionary of Cancer Terms.
U.S. National Cancer Institute.
|
| This oncology article is a stub. You can help Wikipedia by expanding it. |